Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|October 16, 1999
[Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes]C Köhler, T Temelkova-Kurktschiev, F Schaper, et al.Fortschritte Der Medizin|December 20, 1992
[Different effects of fibrates on the lipoprotein profile. Comparison of the effectiveness of gemfibrozil and bezafibrate in various types of hyperlipoproteinemia]U Julius, C Hora, P Gross, et al.Diabetes Care|August 1, 1991
Therapeutic potentials of acarbose as first-line drug in NIDDM insufficiently treated with diet aloneM Hanefeld, S Fischer, J Schulze, et al.Deutsche Medizinische Wochenschrift (1946)|September 23, 2003
[Significance of triglycerides for other metabolic parameters in the familial metabolic syndrome]W Metzler, K Fücker, U Schwanebeck, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|January 1, 1997
Anomalies of lipoprotein pattern and fibrinolysis in acromegalic patients: relation to growth hormone levels and insulin-like growth factor IJ Wildbrett, M Hanefeld, K Fücker, et al.The Clinical Investigator|July 1, 1994
Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal womenU Julius, H Fritsch, W Fritsch, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 17, 1999
Relation of free and specifically bound leptin to insulin secretion in patients with impaired glucose tolerance (IGT)W Leonhardt, R Horn, G Brabant, et al.Acta Diabetologica|October 3, 2002
Insulin-resistant patients with type 2 diabetes mellitus have higher serum leptin levels independently of body fat massS Fischer, M Hanefeld, S M Haffner, et al.Arzneimittel-Forschung|April 1, 1990
Efficacy of a combined bezafibrate retard-colestyramine treatment in patients with hypercholesterolemiaS Fischer, M Hanefeld, P D Lang, et al.Pageof 1